The company said the divestiture of mainstream offerings, including Nature's Bounty and Ester-C, will allow it to prioritize businesses with the "strongest competitive advantage."
The company said the divestiture of mainstream offerings, including Nature's Bounty and Ester-C, will allow it to prioritize businesses with the "strongest competitive advantage."
The page is ready to read now. The fuller skim-friendly version will appear here automatically.
The company said the divestiture of mainstream offerings, including Nature's Bounty and Ester-C, will allow it to prioritize businesses with the "strongest competitive advantage."
Open the app view to save this story, compare related coverage, and continue from the same source.